Equitable access to costly new drugs

Authors

Beth Woods (ORCID: https://orcid.org/0000-0002-7669-9415)
Renske M.T. ten Ham (ORCID: https://orcid.org/0000-0002-2638-8045)
Karl Claxton (ORCID: https://orcid.org/0000-0003-2002-4694)

Institutions

University Medical Center Utrecht (NL)
University of York (GB)

Publication Details

Journal: BMJ
Published: 2025-11-11
DOI: https://doi.org/10.1136/bmj.r2292
Citations: 2
Primary Topic: Pharmaceutical Economics and Policy
Type: article
Field-Weighted Citation Impact: 6.26

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Equitable access to costly new drugs

Beth Woods, Renske M.T. ten Ham, Karl Claxton

Nov 11, 2025

2 citations

BMJ

Pharmaceutical Economics and Policy

6.26

article

Equitable access to costly new drugs

Beth Woods, Renske M.T. ten Ham, Karl Claxton

November 11, 2025article en

2 citations

Abstract

No abstract available for this paper.

BMJVol. 391

University Medical Center Utrecht (NL), University of York (GB)

Openalex Percentile: Top 3%

Pharmaceutical Economics and Policy

6.26

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Equitable access to costly new drugs — Beth Woods, Renske M.T. ten Ham, et al. · BMJ (2025) | TGRS Research Map | TGRS